Inventors:
Michael F. Mullarkey - Seattle WA
International Classification:
C12P 2102, C12N 1500, C07H 1900
Abstract:
Methods and compositions for treating allergic reactions, including cutaneous, ocular, nasal and Bronchial allergic disease, are disclosed. Interleukin-1 and Tumor Necrosis Factor receptors, and analogues thereof, are employed which bind the respective effector competitively and thereby suppress allergic reactions.